Search - tctmd.com

Displaying 61 - 80 of 498

Sort: Relevancy | Date

Presentation TCT 2020

PVL Prevention and Management: TAVR Device Selection, When to Post-Dilate, and When to Plug

Presenter: Hemal Gada

October 16, 2020

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

Presenter: Martin Leon

October 16, 2020

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

Presenter: Philippe Genereux

October 16, 2020

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

Presenter: Michael Reardon

October 16, 2020

Presentation TCT 2020

TAVR in Aortic Bioprosthetic Valve Failure - Thoughtful Perspectives From a Surgeon on Valve-in-Valve TAVR

Presenter: Michael Mack

October 16, 2020

Presentation TCT 2020

How to Assess and Treat INOCA and MINOCA

Presenter: Colin Berry

October 16, 2020

News Industry News

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

October 15, 2020

Presentation TCT 2020

Closure of Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Repair – The Randomized MITHRAS Trial

Presenter: Philipp Lurz

October 15, 2020

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Shelley Wood

October 15, 2020

Presentation TCT 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presenter: Jeffrey W. Moses

October 15, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

Presentation TCT 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presenter: Corrado Tamburino

October 15, 2020

Presentation TCT 2020

Heart Valve Collaboratory Is Next in Line

Presenter: Michael Mack

October 14, 2020

Presentation TCT 2020

LAA Debate: Should LAA Closure Be Widely Adopted? - Epicardial LAA Closure (Lariat): Combining Rhythm Control & Stroke Prevention?

Presenter: Andrea Natale

October 14, 2020

Presentation TCT 2020

LAA Debate: Should LAA Closure Be Widely Adopted? - Absolutely: The Evidence for LAA Closure Is Overwhelming!

Presenter: David Holmes Jr

October 14, 2020

Presentation TCT 2020

Pascal

Presenter: Robert Smith

October 14, 2020

Presentation TCT 2020

Grading FMR Severity: Evolution of the Concept and Evolving Data

Presenter: Paul Grayburn

October 14, 2020

Presentation TCT 2020

MitraClip for FMR - New Insights From COAPT

Presenter: Gregg Stone

October 14, 2020

Presentation TCT 2020

MitraClip for Intermediate Risk DMR - REPAIR MR Trial Design and Controversies

Presenter: Patrick McCarthy

October 14, 2020

Advertisement

PVL Prevention and Management: TAVR Device Selection, When to Post-Dilate, and When to Plug

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

TAVR in Aortic Bioprosthetic Valve Failure - Thoughtful Perspectives From a Surgeon on Valve-in-Valve TAVR

How to Assess and Treat INOCA and MINOCA

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

Closure of Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Repair – The Randomized MITHRAS Trial

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Heart Valve Collaboratory Is Next in Line

LAA Debate: Should LAA Closure Be Widely Adopted? - Epicardial LAA Closure (Lariat): Combining Rhythm Control & Stroke Prevention?

LAA Debate: Should LAA Closure Be Widely Adopted? - Absolutely: The Evidence for LAA Closure Is Overwhelming!

Pascal

Grading FMR Severity: Evolution of the Concept and Evolving Data

MitraClip for FMR - New Insights From COAPT

MitraClip for Intermediate Risk DMR - REPAIR MR Trial Design and Controversies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content